Despite the fact that the decision to severely restrict coverage of an expensive new Alzheimer's medicine, U.S. President Joe Biden...
Read more
Everyone eligible for both shots will often receive them at the same time during the COVID and flu vaccination campaigns...
Read more
In order to ultimately enhance the outcomes and care for children and people with chronic conditions, especially as novel variants...
Read more
The Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership created to advance the development of treatments for...
Read more
According to a study published on September 22nd by U.S. researchers, those who had COVID-19 were more likely to experience a...
Read more
A quarter of patients with a variety of advanced tumours have shown signals of benefit from RP2, a modified form...
Read more
The fixed-dose combination Opdualag (nivolumab and relatlimab) from Bristol Myers Squibb (BMS) has received clearance from the European Commission for...
Read more
Within one firm, the title of most costly treatment in the world has changed hands within a month. Bluebird Bio...
Read more
QIAGEN and Neuron23TM Inc., an early-stage biotechnology company focused on creating precision medications for genetically defined neurological and immunological illnesses,...
Read more
Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer....
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
